Cours Leviathan Cannabis Group Inc Canadian Securities Exchange
Actions
CA61762Y1051
Produits pharmaceutiques
CA 2022 | 842 k 613 k 575 k | CA 2023 | 35,34 M 25,69 M 24,13 M | Capitalisation | 219 M 159 M 149 M |
---|---|---|---|---|---|
Résultat net 2022 | -4 M -2,91 M -2,73 M | Résultat net 2023 | - 0 0 | VE / CA 2022 | 150 x |
Dette nette 2022 | 8,9 M 6,47 M 6,07 M | Dette nette 2023 | 3,32 M 2,41 M 2,26 M | VE / CA 2023 | 6,28 x |
PER 2022 |
-23,4
x | PER 2023 |
-238
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 87,12 % |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Tanvi Bhandari
CEO | Chief Executive Officer | - | 07/03/22 |
Director of Finance/CFO | - | 07/03/22 | |
Kamyar Hosseini
CTO | Chief Tech/Sci/R&D Officer | - | - |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Tanvi Bhandari
CEO | Chief Executive Officer | - | 07/03/22 |
Rupalee Mehta
BRD | Director/Board Member | - | 07/03/22 |
Lucas Leone
BRD | Director/Board Member | - | 07/03/22 |
Varia. 1 janv. | Capi. | |
---|---|---|
+24,77 % | 672 Md | |
+24,08 % | 550 Md | |
-5,91 % | 351 Md | |
+15,42 % | 317 Md | |
+7,03 % | 292 Md | |
+3,26 % | 211 Md | |
+0,78 % | 203 Md | |
-9,95 % | 144 Md | |
-7,05 % | 141 Md |